PCSK9 Inhibitors May Lower Cholesterol in Patients with Statin-Associated Immune-Mediated Necrotizing Myopathy

A 2019 study demonstrated the benefit of a newer drug class, PCSK9 inhibitors, to help lower cholesterol in patients with statin-associated immune-mediated necrotizing myopathy...
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Drug Updates Arthritis & Rheumatology cholesterol immune-mediated necrotizing myopathy PCSK9 inhibitors protein convertase subtilisin/kexin type 9 inhibitors statin-associated myopathy Source Type: research